Lake Ryan David
Insider CIK 1450325 · LFCR Chief Financial Officer · REPH Senior VP, Finance & CAO · BXRX Chief Financial Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| LFCR LIFECORE BIOMEDICAL, INC. | F Tax w/h | 2025-09-03 | 2025-09-04 | 22,932 | $7.71 | $176.8K | 336,691 | SEC↗ |
| LFCR LIFECORE BIOMEDICAL, INC. | M Exercise deriv | 2025-07-08 | 2025-07-10 | 75,000 | — | $0 | 600,000 | SEC↗ |
| LFCR LIFECORE BIOMEDICAL, INC. | F Tax w/h | 2025-07-08 | 2025-07-10 | 32,806 | $8.19 | $268.7K | 359,623 | SEC↗ |
| LFCR LIFECORE BIOMEDICAL, INC. | M Exercise | 2025-07-08 | 2025-07-10 | 75,000 | — | $0 | 392,429 | SEC↗ |
| LFCR LIFECORE BIOMEDICAL, INC. | A Award | 2024-12-06 | 2024-12-10 | 19,720 | — | $0 | 323,082 | SEC↗ |
| LFCR LIFECORE BIOMEDICAL, INC. | F Tax w/h | 2024-12-06 | 2024-12-10 | 5,653 | $7.15 | $40.4K | 317,429 | SEC↗ |
| LFCR LIFECORE BIOMEDICAL, INC. | F Tax w/h | 2024-10-07 | 2024-10-29 | 34,138 | $5.09 | $173.8K | 303,362 | SEC↗ |
| LFCR LIFECORE BIOMEDICAL, INC. | M Exercise | 2024-10-07 | 2024-10-29 | 75,000 | — | $0 | 337,500 | SEC↗ |
| LFCR LIFECORE BIOMEDICAL, INC. | A Award deriv | 2024-09-03 | 2024-09-05 | 750,000 | — | $0 | 0 | SEC↗ |
| LFCR LIFECORE BIOMEDICAL, INC. | A Award | 2024-09-03 | 2024-09-05 | 262,500 | — | $0 | 262,500 | SEC↗ |
| SCTL Societal CDMO, Inc. | D To issuer | 2024-04-08 | 2024-04-08 | 1,049,287 | $1.10 | $1.15M | 0 | SEC↗ |
| SCTL Societal CDMO, Inc. | U Tender | 2024-04-08 | 2024-04-08 | 522,699 | $1.10 | $575.0K | 1,049,287 | SEC↗ |
| SCTL Societal CDMO, Inc. | A Award | 2024-02-29 | 2024-03-04 | 771,429 | — | $0 | 1,571,986 | SEC↗ |
| SCTL Societal CDMO, Inc. | F Tax w/h | 2024-02-03 | 2024-02-06 | 1,022 | $0.45 | $460 | 800,557 | SEC↗ |
| SCTL Societal CDMO, Inc. | F Tax w/h | 2024-01-24 | 2024-01-26 | 37,453 | $0.35 | $13.1K | 801,579 | SEC↗ |
| SCTL Societal CDMO, Inc. | A Award | 2024-01-24 | 2024-01-26 | 110,025 | — | $0 | 839,032 | SEC↗ |
| SCTL Societal CDMO, Inc. | F Tax w/h | 2024-01-20 | 2024-01-23 | 14,442 | $0.35 | $5.1K | 729,007 | SEC↗ |
| SCTL Societal CDMO, Inc. | F Tax w/h | 2024-01-19 | 2024-01-23 | 19,654 | $0.35 | $6.9K | 743,449 | SEC↗ |
| SCTL Societal CDMO, Inc. | F Tax w/h | 2024-01-02 | 2024-01-04 | 1,419 | $0.41 | $582 | 763,103 | SEC↗ |
| SCTL Societal CDMO, Inc. | F Tax w/h | 2023-12-15 | 2023-12-19 | 5,690 | $0.37 | $2.1K | 764,522 | SEC↗ |
| SCTL Societal CDMO, Inc. | F Tax w/h | 2023-11-30 | 2023-12-04 | 1,197 | $0.37 | $443 | 770,212 | SEC↗ |
| SCTL Societal CDMO, Inc. | F Tax w/h | 2023-10-31 | 2023-11-02 | 1,198 | $0.34 | $407 | 771,409 | SEC↗ |
| SCTL Societal CDMO, Inc. | F Tax w/h | 2023-09-30 | 2023-10-04 | 1,198 | $0.46 | $551 | 772,607 | SEC↗ |
| SCTL Societal CDMO, Inc. | F Tax w/h | 2023-08-31 | 2023-09-05 | 1,197 | $0.57 | $682 | 773,805 | SEC↗ |
| SCTL Societal CDMO, Inc. | F Tax w/h | 2023-07-31 | 2023-08-02 | 1,198 | $0.85 | $1.0K | 775,002 | SEC↗ |
| SCTL Societal CDMO, Inc. | F Tax w/h | 2023-06-30 | 2023-07-05 | 1,198 | $1.10 | $1.3K | 776,200 | SEC↗ |
| SCTL Societal CDMO, Inc. | F Tax w/h | 2023-05-31 | 2023-06-02 | 1,197 | $0.70 | $838 | 777,398 | SEC↗ |
| SCTL Societal CDMO, Inc. | F Tax w/h | 2023-05-01 | 2023-05-03 | 1,198 | $0.74 | $887 | 778,595 | SEC↗ |
| SCTL Societal CDMO, Inc. | F Tax w/h | 2023-03-31 | 2023-04-04 | 1,198 | $1.19 | $1.4K | 779,793 | SEC↗ |
| SCTL Societal CDMO, Inc. | F Tax w/h | 2023-02-28 | 2023-03-02 | 1,197 | $1.47 | $1.8K | 780,991 | SEC↗ |
| SCTL Societal CDMO, Inc. | F Tax w/h | 2023-02-03 | 2023-02-08 | 862 | $1.36 | $1.2K | 782,188 | SEC↗ |
| SCTL Societal CDMO, Inc. | F Tax w/h | 2023-01-31 | 2023-02-02 | 1,198 | $1.30 | $1.6K | 783,050 | SEC↗ |
| SCTL Societal CDMO, Inc. | F Tax w/h | 2023-01-20 | 2023-01-23 | 14,438 | $1.36 | $19.6K | 784,248 | SEC↗ |
| SCTL Societal CDMO, Inc. | A Award deriv | 2023-01-19 | 2023-01-23 | 160,929 | — | $0 | 160,929 | SEC↗ |
| SCTL Societal CDMO, Inc. | A Award | 2023-01-19 | 2023-01-23 | 84,848 | — | $0 | 596,116 | SEC↗ |
| SCTL Societal CDMO, Inc. | F Tax w/h | 2023-01-19 | 2023-01-23 | 28,374 | $1.35 | $38.3K | 567,742 | SEC↗ |
| SCTL Societal CDMO, Inc. | A Award | 2023-01-19 | 2023-01-23 | 230,944 | — | $0 | 798,686 | SEC↗ |
| SCTL Societal CDMO, Inc. | F Tax w/h | 2023-01-18 | 2023-01-20 | 1,094 | $1.30 | $1.4K | 511,268 | SEC↗ |
| SCTL Societal CDMO, Inc. | F Tax w/h | 2023-01-03 | 2023-01-05 | 1,419 | $1.40 | $2.0K | 512,362 | SEC↗ |
| SCTL Societal CDMO, Inc. | F Tax w/h | 2022-12-15 | 2022-12-19 | 5,690 | $1.33 | $7.6K | 513,781 | SEC↗ |
| SCTL Societal CDMO, Inc. | F Tax w/h | 2022-11-30 | 2022-12-01 | 1,197 | $1.80 | $2.2K | 519,471 | SEC↗ |
| SCTL Societal CDMO, Inc. | F Tax w/h | 2022-10-31 | 2022-11-02 | 1,198 | $1.82 | $2.2K | 520,668 | SEC↗ |
| SCTL Societal CDMO, Inc. | F Tax w/h | 2022-09-30 | 2022-10-04 | 1,198 | $1.63 | $2.0K | 521,866 | SEC↗ |
| SCTL Societal CDMO, Inc. | F Tax w/h | 2022-08-31 | 2022-09-02 | 1,197 | $1.19 | $1.4K | 523,064 | SEC↗ |
| SCTL Societal CDMO, Inc. | F Tax w/h | 2022-08-01 | 2022-08-02 | 1,198 | $0.92 | $1.1K | 524,261 | SEC↗ |
| SCTL Societal CDMO, Inc. | F Tax w/h | 2022-06-30 | 2022-07-05 | 1,198 | $0.80 | $958 | 525,459 | SEC↗ |
| SCTL Societal CDMO, Inc. | F Tax w/h | 2022-05-31 | 2022-06-02 | 1,197 | $0.74 | $886 | 526,657 | SEC↗ |
| SCTL Societal CDMO, Inc. | F Tax w/h | 2022-04-30 | 2022-05-03 | 1,198 | $1.34 | $1.6K | 527,854 | SEC↗ |
| SCTL Societal CDMO, Inc. | F Tax w/h | 2022-03-31 | 2022-04-04 | 1,198 | $1.80 | $2.2K | 529,052 | SEC↗ |
| SCTL Societal CDMO, Inc. | F Tax w/h | 2022-02-28 | 2022-04-04 | 1,197 | $1.66 | $2.0K | 530,250 | SEC↗ |
| REPH Recro Pharma, Inc. | F Tax w/h | 2022-02-03 | 2022-02-04 | 1,021 | $1.54 | $1.6K | 544,753 | SEC↗ |
| REPH Recro Pharma, Inc. | F Tax w/h | 2022-01-31 | 2022-02-02 | 1,419 | $1.54 | $2.2K | 545,774 | SEC↗ |
| SCTL Societal CDMO, Inc. | F Tax w/h | 2022-01-20 | 2022-04-04 | 13,306 | $1.65 | $22.0K | 533,887 | SEC↗ |
| REPH Recro Pharma, Inc. | A Award deriv | 2022-01-20 | 2022-01-24 | 247,788 | — | $0 | 247,788 | SEC↗ |
| REPH Recro Pharma, Inc. | A Award | 2022-01-20 | 2022-01-24 | 169,697 | — | $0 | 547,193 | SEC↗ |
| REPH Recro Pharma, Inc. | A Award | 2022-01-20 | 2022-01-24 | 39,604 | — | $0 | 377,496 | SEC↗ |
| REPH Recro Pharma, Inc. | F Tax w/h | 2022-01-18 | 2022-01-19 | 1,094 | $1.65 | $1.8K | 337,892 | SEC↗ |
| REPH Recro Pharma, Inc. | F Tax w/h | 2022-01-03 | 2022-01-04 | 979 | $1.74 | $1.7K | 338,986 | SEC↗ |
| REPH Recro Pharma, Inc. | F Tax w/h | 2021-12-31 | 2022-01-04 | 28,730 | $1.71 | $49.1K | 339,965 | SEC↗ |
| REPH Recro Pharma, Inc. | F Tax w/h | 2021-12-15 | 2021-12-17 | 5,690 | $1.61 | $9.2K | 368,695 | SEC↗ |
| REPH Recro Pharma, Inc. | P Buy | 2021-11-12 | 2021-11-16 | 1,162 | $1.65 | $1.9K | 374,335 | SEC↗ |
| REPH Recro Pharma, Inc. | P Buy | 2021-11-12 | 2021-11-16 | 50 | $1.62 | $81 | 374,385 | SEC↗ |
| REPH Recro Pharma, Inc. | F Tax w/h | 2021-07-08 | 2021-07-13 | 5,172 | $1.96 | $10.1K | 373,173 | SEC↗ |
| REPH Recro Pharma, Inc. | F Tax w/h | 2021-06-07 | 2021-06-08 | 719 | $2.30 | $1.7K | 378,345 | SEC↗ |
| REPH Recro Pharma, Inc. | M Exercise deriv | 2021-06-05 | 2021-06-08 | 2,500 | — | $0 | 0 | SEC↗ |
| REPH Recro Pharma, Inc. | M Exercise | 2021-06-05 | 2021-06-08 | 2,500 | — | $0 | 379,064 | SEC↗ |
| REPH Recro Pharma, Inc. | F Tax w/h | 2021-04-08 | 2021-04-12 | 5,172 | $3.24 | $16.8K | 376,564 | SEC↗ |
| REPH Recro Pharma, Inc. | F Tax w/h | 2021-02-03 | 2021-02-12 | 1,075 | $3.74 | $4.0K | 381,736 | SEC↗ |
| REPH Recro Pharma, Inc. | F Tax w/h | 2021-01-18 | 2021-01-20 | 1,352 | $3.03 | $4.1K | 382,811 | SEC↗ |
| BXRX Baudax Bio, Inc. | A Award deriv | 2021-01-15 | 2021-01-20 | 23,077 | — | $0 | 23,077 | SEC↗ |
| BXRX Baudax Bio, Inc. | A Award deriv | 2021-01-15 | 2021-01-20 | 60,000 | — | $0 | 60,000 | SEC↗ |
| BXRX Baudax Bio, Inc. | A Award | 2021-01-15 | 2021-01-20 | 20,000 | — | $0 | 95,909 | SEC↗ |
| BXRX Baudax Bio, Inc. | F Tax w/h | 2021-01-15 | 2021-01-20 | 26,658 | $1.30 | $34.7K | 69,251 | SEC↗ |
| BXRX Baudax Bio, Inc. | A Award | 2021-01-15 | 2021-01-20 | 5,000 | — | $0 | 75,909 | SEC↗ |
| REPH | A Award | 2021-01-08 | 2021-01-12 | 200,000 | — | $0 | 366,773 | SEC↗ |
| REPH | A Award | 2021-01-08 | 2021-01-12 | 30,000 | — | $0 | 396,773 | SEC↗ |
| REPH | F Tax w/h | 2021-01-08 | 2021-01-12 | 12,610 | $2.99 | $37.7K | 384,163 | SEC↗ |
| REPH | A Award | 2021-01-08 | 2021-01-12 | 36,000 | — | $0 | 166,773 | SEC↗ |
| REPH Recro Pharma, Inc. | F Tax w/h | 2021-01-02 | 2021-01-05 | 1,210 | $3.09 | $3.7K | 130,773 | SEC↗ |
| REPH Recro Pharma, Inc. | A Award deriv | 2020-12-15 | 2020-12-18 | 116,505 | — | $0 | 116,505 | SEC↗ |
| REPH Recro Pharma, Inc. | A Award | 2020-12-15 | 2020-12-18 | 79,208 | — | $0 | 131,983 | SEC↗ |
| REPH Recro Pharma, Inc. | F Tax w/h | 2020-12-05 | 2020-12-09 | 7,611 | $2.30 | $17.5K | 52,775 | SEC↗ |
| BXRX Baudax Bio, Inc. | F Tax w/h | 2020-12-05 | 2020-12-09 | 4,845 | $1.14 | $5.5K | 70,909 | SEC↗ |
| BXRX Baudax Bio, Inc. | F Tax w/h | 2020-12-05 | 2020-12-09 | 15,064 | $1.14 | $17.2K | 75,754 | SEC↗ |
| REPH Recro Pharma, Inc. | M Exercise deriv | 2020-06-05 | 2020-06-09 | 2,500 | — | $0 | 2,500 | SEC↗ |
| REPH Recro Pharma, Inc. | F Tax w/h | 2020-06-05 | 2020-06-09 | 852 | $4.95 | $4.2K | 60,386 | SEC↗ |
| REPH Recro Pharma, Inc. | M Exercise | 2020-06-05 | 2020-06-09 | 2,500 | — | $0 | 61,238 | SEC↗ |
| REPH Recro Pharma, Inc. | A Award deriv | 2020-02-03 | 2020-02-05 | 45,000 | — | $0 | 45,000 | SEC↗ |
| REPH Recro Pharma, Inc. | A Award | 2020-02-03 | 2020-02-05 | 12,000 | — | $0 | 58,738 | SEC↗ |
| BXRX Baudax Bio, Inc. | M Exercise | 2020-01-27 | 2020-01-29 | 6,000 | — | $0 | 92,543 | SEC↗ |
| BXRX Baudax Bio, Inc. | F Tax w/h | 2020-01-27 | 2020-01-29 | 1,725 | $8.51 | $14.7K | 90,818 | SEC↗ |
| REPH Recro Pharma, Inc. | F Tax w/h | 2020-01-18 | 2020-01-22 | 1,095 | $16.38 | $17.9K | 46,738 | SEC↗ |
| REPH Recro Pharma, Inc. | F Tax w/h | 2020-01-02 | 2020-01-03 | 979 | $17.53 | $17.2K | 47,833 | SEC↗ |
| BXRX Baudax Bio, Inc. | A Award deriv | 2019-12-05 | 2019-12-09 | 66,327 | — | $0 | 66,327 | SEC↗ |
| BXRX Baudax Bio, Inc. | A Award | 2019-12-05 | 2019-12-09 | 36,096 | — | $0 | 40,114 | SEC↗ |
| BXRX Baudax Bio, Inc. | A Award | 2019-12-05 | 2019-12-09 | 46,429 | — | $0 | 86,543 | SEC↗ |
| REPH Recro Pharma, Inc. | A Award | 2019-12-05 | 2019-12-09 | 17,283 | — | $0 | 48,812 | SEC↗ |
| REPH Recro Pharma, Inc. | M Exercise deriv | 2019-06-05 | 2019-06-07 | 2,500 | — | $0 | 5,000 | SEC↗ |
| REPH Recro Pharma, Inc. | F Tax w/h | 2019-06-05 | 2019-06-07 | 719 | $9.55 | $6.9K | 31,529 | SEC↗ |
| REPH Recro Pharma, Inc. | M Exercise | 2019-06-05 | 2019-06-07 | 2,500 | — | $0 | 32,248 | SEC↗ |
| REPH Recro Pharma, Inc. | F Tax w/h | 2019-01-20 | 2019-01-23 | 1,880 | $7.99 | $15.0K | 28,155 | SEC↗ |
| REPH Recro Pharma, Inc. | A Award | 2019-01-20 | 2019-01-23 | 5,750 | — | $0 | 30,035 | SEC↗ |
| REPH Recro Pharma, Inc. | A Award | 2019-01-20 | 2019-02-19 | 5,750 | — | $0 | 31,628 | SEC↗ |
| REPH Recro Pharma, Inc. | F Tax w/h | 2019-01-20 | 2019-02-19 | 1,880 | $7.99 | $15.0K | 29,748 | SEC↗ |
| REPH Recro Pharma, Inc. | A Award deriv | 2019-01-18 | 2019-01-23 | 53,859 | — | $0 | 53,859 | SEC↗ |
| REPH Recro Pharma, Inc. | A Award deriv | 2019-01-18 | 2019-02-19 | 60,000 | — | $0 | 60,000 | SEC↗ |
| REPH Recro Pharma, Inc. | A Award | 2019-01-18 | 2019-01-23 | 11,264 | — | $0 | 24,285 | SEC↗ |
| REPH Recro Pharma, Inc. | A Award | 2019-01-18 | 2019-02-19 | 12,857 | — | $0 | 25,878 | SEC↗ |
| REPH Recro Pharma, Inc. | F Tax w/h | 2019-01-02 | 2019-01-04 | 979 | $7.41 | $7.3K | 13,021 | SEC↗ |
| REPH Recro Pharma, Inc. | F Tax w/h | 2019-01-02 | 2019-01-04 | 979 | $7.41 | $7.3K | 13,021 | SEC↗ |
| REPH Recro Pharma, Inc. | M Exercise deriv | 2018-06-05 | 2018-06-07 | 2,500 | — | $0 | 7,500 | SEC↗ |
| REPH Recro Pharma, Inc. | M Exercise | 2018-06-05 | 2018-06-07 | 2,500 | — | $0 | 14,000 | SEC↗ |
| REPH Recro Pharma, Inc. | A Award deriv | 2018-01-02 | 2018-01-04 | 23,000 | — | $0 | 23,000 | SEC↗ |
| REPH Recro Pharma, Inc. | A Award | 2018-01-02 | 2018-01-04 | 11,500 | — | $0 | 11,500 | SEC↗ |
| REPH Recro Pharma, Inc. | A Award deriv | 2017-06-05 | 2017-06-07 | 65,000 | — | $0 | 65,000 | SEC↗ |
| REPH Recro Pharma, Inc. | A Award deriv | 2017-06-05 | 2017-06-07 | 10,000 | — | $0 | 10,000 | SEC↗ |